Overview

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ

Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The investigators plan to prospectively study breast tissue changes after a short course of Tamoxifen (Tam).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Amy C. Degnim
Treatments:
Afimoxifene
Hydroxytamoxifen
Tamoxifen